Drug Type Small molecule drug |
Synonyms 조은아이부릉시럽 |
Target |
Action agonists, antagonists |
Mechanism A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (26 Sep 2024), |
Regulation- |
Molecular FormulaC8H11NO3 |
InChIKeyLXNHXLLTXMVWPM-UHFFFAOYSA-N |
CAS Registry65-23-6 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Motion Sickness | South Korea | 26 Sep 2024 |





